J&J International Baby, Beauty Lines Could Lead Trimming 10% Of Consumer Portfolio

J&J plans to cut 10% of its consumer health portfolio, with most divestitures in the baby and beauty care segments outside the US. It plans to focus on growing “stronghold” categories of skin health and self care, including Aveeno and Tylenol.

Piz Buin sunscreen line
Piz Buin moisturing products J&J markets in international markets are among the SKUs the firm could prioritze divesting in its planned consumer business trimming.

Johnson & Johnson plans to cut 10% of consumer health SKUs, mainly in the baby and beauty categories outside the US and primarily in the second half of the year.

During J&J’s 2019 fourth-quarter earnings briefing on 22 January, Chief Financial Officer Joseph Wolk said the trimming is anticipated to negatively impact 2020

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on HBW Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from Earnings

More from Business